Jump to navigation

South Africa

Experts and activists demand more generous vaccine waivers

Over a year after India and South Africa called for emergency measures, WTO members have proposed a plan to waive patents on COVID-19 vaccines

Pressure is building on President Cyril Ramaphosa to reject a compromise proposal offered by the United States and the European Union for a temporary waiver of intellectual property (IP) on Covid-19 vaccines (AC Vol 63 No 7, Vaccine patent negotiators agree compromise formula).

Over 300 civic activists, trades unions, academics, and experts from across the world, including economics laureate Joseph Stiglitz wrote to India's Prime Minister Narendra Modi and Ramaphosa describing the leaked text on IP waivers 'inadequate' and 'a step backwards from an already untenable status quo.'

It is almost 18 months since India and South Africa asked the World Trade Organization to waive IP rights for medicines in the hope of aiding the 'prevention, containment and treatment of Covid-19'.

South African and Indian officials joined the talks that led to the compromise text prepared by the US and EU, but Ramaphosa and his ministers are yet to comment on its contents.

The leaked text proposes that the waiver would cover IP rights only on vaccines but not on treatments for Covid-19. It also states that, within six months of a final agreement, WTO members must decide on whether to extend it to include Covid-19 diagnostics and therapeutics as well. For the moment, there is no timetable for a full WTO meeting to approve or reject the plan. It would require consensus support.

It also suggested that the agreement would be restricted to five years. The waiver would apply to those WTO members that exported less than 10% of the world's vaccine doses in 2021; that provision would mean the EU, China, and the US could not benefit from the waiver.

The proposal, despite its modesty, is opposed by the pharmaceutical conglomerates. The European Federation of Pharmaceutical Industries and Associations (EFPIA) called 'on governments across Europe and around the world to urgently rethink discussions on a Covid vaccine waiver and instead focus on the real barriers to global vaccine equity'.



Related Articles

DISPATCHES

Vaccine patent negotiators agree compromise formula

World Trade Organization chief Okonjo-Iweala applauds progress but warns of struggle to convince all members states to back it

The lead team of negotiators has agreed a compromise on patents waiver over three to five years for Covid-19 vaccines which will require ratification by all WTO members....

READ FOR FREE

NePAD doubts mount up

With its emphasis on new concepts of African collective responsibility and its promise of strong moral and financial support from Western countries, the New Partnership for African Development...


New powers, new policy

The government reshapes strategy to address new political realities - and life after Thabo Mbeki

A growing and diversified economy, a liberal constitution, a big army and residual post-apartheid moral high ground makes Tshwane (formerly Pretoria) a natural centre for African diplomacy. It...


Mbeki the mystery

The new cabinet reveals little about the new President's political style

Now centre-stage as President, Thabo Mbeki still keeps South Africans guessing. His patchwork cabinet is dominated by ministers who served Nelson Mandela, and expanded to 29 from 26...